Celanese CE has been analyzed by 15 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 1 | 4 | 7 | 2 | 1 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 2 | 0 | 0 |
2M Ago | 1 | 2 | 5 | 2 | 1 |
3M Ago | 0 | 1 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $106.07, a high estimate of $163.00, and a low estimate of $73.00. Highlighting a 24.81% decrease, the current average has fallen from the previous average price target of $141.07.
Analyzing Analyst Ratings: A Detailed Breakdown
A comprehensive examination of how financial experts perceive Celanese is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Arun Viswanathan | RBC Capital | Lowers | Outperform | $88.00 | $122.00 |
Patrick Cunningham | Citigroup | Lowers | Neutral | $73.00 | $100.00 |
Michael Leithead | Barclays | Lowers | Equal-Weight | $88.00 | $101.00 |
Joshua Spector | UBS | Lowers | Neutral | $97.00 | $161.00 |
John McNulty | BMO Capital | Lowers | Underperform | $76.00 | $138.00 |
Charles Neivert | Piper Sandler | Lowers | Underweight | $98.00 | $150.00 |
Arun Viswanathan | RBC Capital | Lowers | Outperform | $122.00 | $163.00 |
Michael Leithead | Barclays | Lowers | Equal-Weight | $101.00 | $151.00 |
Ghansham Panjabi | Baird | Lowers | Outperform | $110.00 | $150.00 |
Vincent Andrews | Morgan Stanley | Lowers | Equal-Weight | $100.00 | $140.00 |
David Begleiter | Deutsche Bank | Lowers | Buy | $110.00 | $135.00 |
Kieran De Brun | Mizuho | Lowers | Neutral | $120.00 | $132.00 |
Michael Sison | Wells Fargo | Lowers | Equal-Weight | $115.00 | $165.00 |
Kevin McCarthy | Vertical Research | Announces | Sell | $130.00 | - |
Arun Viswanathan | RBC Capital | Lowers | Outperform | $163.00 | $167.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Celanese. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Celanese's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Celanese's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Celanese analyst ratings.
All You Need to Know About Celanese
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
A Deep Dive into Celanese's Financials
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Decline in Revenue: Over the 3 months period, Celanese faced challenges, resulting in a decline of approximately -2.75% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Celanese's net margin is impressive, surpassing industry averages. With a net margin of 4.38%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Celanese's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.61% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Celanese's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.45%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 1.83, Celanese faces challenges in effectively managing its debt levels, indicating potential financial strain.
Understanding the Relevance of Analyst Ratings
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.